Roche Australia Website Terms of Use

This website is owned and operated by Roche Products Pty Ltd (ABN 70 000 132 865), Roche Diagnostics Australia Pty Limited (ABN 29 003 001 205) and Roche Diabetes Care Australia Pty Limited (ABN 69 602 140 278) and their successors and assignees (referred to as “we”, “us” and “our”). It is available at:and may also be available through other addresses (together, “Site”).

These terms apply to you, the person, organisation or entity that uses the Site (referred to as “you” or “your”) and the terms form a contract between you and us if you use the Site. Please read these terms carefully. If you have any questions, please contact us using the "contact" button below. Your use of the Site indicates that you have read and accepted these terms. The information on the Site, and these terms may be amended from time to time. Your continued engagement with us and use of our products and services after any amendments are made indicates that you accept the amendments. You should check the terms regularly to ensure you are aware of any changes, and only proceed to use the Site if you accept and will comply with the new terms. Some of the terms relate specifically to the supply of medicines, patient solutions and services by Roche Products Pty Ltd that may result from enrolments or applications you make on behalf of patients seeking access to our medicines by using the Site.

1. Site content disclaimer: The information contained on the Site, apart from product information, is for general information purposes only.  It does not take into account your, or any patient’s specific needs or circumstances, and it is not professional advice.  Before acting on any such information, you should consider whether it is appropriate for you and/or your patients. The information does not constitute an offer of or solicitation for transacting in any Roche securities and where forward looking information is presented it is subject to many uncertainties and actual results may differ significantly from those presented.  Links to third party pages are provided for convenience only and we do not express any opinion on the content of those pages. We make no representations or warranties, express or implied, as to the accuracy or completeness of the information. You agree that your access to and use of the Site is at your own risk and neither we nor any other party involved in creating, producing or delivering the Site will be liable for any direct or indirect loss or damage arising out of your use of or access to or inability to use or access the Site or any Site linked to it.

2. Roche Products access to medicines pathways (RAMP) terms: We will supply patients with access to medicines on the following terms:

(a) We may agree to supply our medicines on a subsidised basis or co-payment basis, and on a continuing basis or a limited quantity, depending on the type of RAMP pathway that a patient has been enrolled into, or the type of assistance that has been requested on behalf of a patient and that we have agreed to. We may choose not to supply our medicines at any time at our absolute discretion.

(b) Examples of circumstances where supply will stop include, but are not limited to, changes in Therapeutic Goods Administration (TGA) registration of the medicine, listing of the medicine on the pharmaceutical  benefits scheme, divestment of the medicine, unavailability of the medicine in Australia, changes in the safety profile of the medicine and if in the physician's opinion, the patient is no longer receiving clinical benefit.

(c) We consider access to medicine requests on a case-by-case basis and only consider those received from healthcare professionals registered to practice medicine in Australia. It is the responsibility of the requesting healthcare professional to obtain appropriate informed consent from the patient.

(d) Patients who are receiving medicines under a RAMP must at all times meet the relevant criteria  for supply to continue.

(e) We may invoice a party that orders our medicine once it has been supplied, even if it has not been not used by the patient for whom it was ordered.

(f) In all cases we will only re-supply medicines on receipt of a written request from a healthcare professional registered to practice medicine in Australia using our required form and accompanied by any evidence supporting funding of previous treatments that we may require. Continuation of supply is subject to the patient continuing to benefit from the treatment and meeting any relevant TGA requirements (including the special access scheme requirements).

(g) If the use requested is an unapproved use, you accept, to the extent permitted by law, any liability and risks associated with the prescription and/or use of the medicine. If you are a prescriber, we will supply you with relevant information that we have about the medicine on the basis that you agree to keep that information confidential.

(h)  We may send electronic notifications to you concerning the RAMP access (or RAMP access pathway) for a patient, including requests for proof of purchase and confirmation of supply.

(i)  Continuation of supply of medicines under a RAMP pathway is subject to a request from the treating HCP (including confirmation that the patient continues to benefit from the treatment), meeting any relevant TGA requirements (including the special access scheme requirements) and submission of a new application to Roche for each relevant RAMP pathway duration period prior to the end of the current period.

(j) Special pharmacovigilance reporting requirements must be agreed by each treating physician upon registering with RAMP, and prior to requesting medicines for their patients. Such requirements will form part of these terms.

3. Pharmacovigilance: To report a suspected side effect or product complaint associated with the use of a Roche product, visitor contact Roche Patient Safety at

4. Intellectual property rights: The Site contains material which is owned by or licensed to us and is protected by Australian and international intellectual property laws, including but not limited to the content, branding and look and feel of the Site. You agree not to do anything to infringe those rights, including but not limited to:

(a) copying, altering, modifying or creating derivative works from any of the code on the Site or the content;

(b) framing or embedding the Site or any part of it in another website; or

(c) linking the Site or any part of it to another website, without obtaining our prior written permission, which we may withhold in our absolute discretion.

5. Use of the Site: You also agree not to:

(a) use the Site other than for obtaining general information for your own use;

(b) use the Site in violation of any applicable laws or any legal rights (including, but not limited to, privacy laws);

(c) use the Site in order to compete with our business;

(d) attempt to or tamper with, hinder or modify the Site, knowingly transmit viruses or other disabling features, or damage or interfere with the Site; or

(e) assist a third party to do any of the above acts.

6. Privacy: Please read our Privacy Policy which is available on the Site. By agreeing to these terms, you also agree to the terms of our Privacy Policy. You represent  that by including personal information of another person in any field or form on a Site , you have complied with requirements of the Privacy Act 1988 (Cth) or its equivalent,  including, but not limited to, obtaining required consent(s) from the person(s) whose personal information is being disclosed.

7. Amending, deleting and blocking: We may amend or delete any and all content or links and block any user in our sole discretion.

8. Availability of the Site: We are not responsible for any delays on or interruptions to the Site. We may at any time and without notice discontinue the Site in whole or in part.

9. No waiver: If we do not act in relation to a breach of these terms by you, this does not waive our rights to act with respect to subsequent or similar breaches of these terms by you.

10. Enforceability: If any of these terms is found to be illegal, invalid or unenforceable this will not affect the remainder of these terms, which will continue in full force and effect.

11. Further assurances: We and you both agree, at our own expense, to act in good faith at all times and to do everything reasonably necessary to give full effect to these terms.

12. Disputes: We and you agree to use alternative dispute resolution including but not limited to negotiation and mediation to resolve any dispute arising out of or relating to these terms, prior to resorting to court proceedings.

13. Limited liability: to the maximum extent permitted by laws, we are not responsible for any loss, cost, damage, liability, expense, howsoever arising, suffered by you or any third party, arising from or in connection with your use of the Site and/or information contained on the Site  and/or any inaccessibility of, interruption or delay to or outage of our Site, or any loss or corruption of data.

14. Jurisdiction: These terms are subject to the laws of New South Wales and the Commonwealth of Australia and we and you both submit to the non-exclusive jurisdiction of the courts of those jurisdictions.

Version dated August 2024

Roche Products Pty Limited ABN 70 000 132 865 | Roche Diagnostics Australia Pty Limited ABN 29 003 001 205 | Roche Diabetes Care Australia Pty Limited ABN 69 602 140 278. This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances. To report a suspected side effect or product complaint associated with the use of a Roche product, visitor contact Roche Patient Safety atRoche acknowledges the Traditional Owners of Country throughout Australia. We pay our respects to Elders past and present.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeAbout RochePharma solutionsDiagnostic solutionsRoche careersMediaPrivacy policyTerms of use